Table 5. Comparison of antimicrobial susceptibility between extended spectrum-β lactamase producing Escherichia coli and Klebsiella pneumoniae in healthcare-associated acute pyelonephritis.
|
E. coli (n = 48) N (%) |
K. pneumoniae (n = 30) N (%) |
P value | |
|---|---|---|---|
| Amikacin | 46 (95.8%) | 27 (90.0%) | 0.367 |
| Gentamicin | 16 (33.3%) | 20 (66.7%) | 0.004 |
| Ciprofloxacin | 5 (10.4%) | 11 (36.7%) | 0.005 |
| Cefepime | 0 (0.0%) | 0 (0.0%) | - |
| Piperacillin/tazobactam | 36 (75.0%) | 14 (46.7%) | 0.011 |
| Trimethoprim/sulfamethoxazole | 17 (35.4%) | 10 (33.3%) | 0.851 |